These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10355058)

  • 21. Safety and efficacy of the biologic response modifiers.
    Markenson J
    Am J Orthop (Belle Mead NJ); 2007 Mar; 36(3 Suppl):15-9. PubMed ID: 17491583
    [No Abstract]   [Full Text] [Related]  

  • 22. How antirheumatic drugs protect joints from damage in rheumatoid arthritis.
    Schett G; Stach C; Zwerina J; Voll R; Manger B
    Arthritis Rheum; 2008 Oct; 58(10):2936-48. PubMed ID: 18821703
    [No Abstract]   [Full Text] [Related]  

  • 23. Thrombogenicity of TNF alpha in rheumatoid arthritis defined through biological probes: TNF alpha blockers.
    Ferraccioli G; Gremese E
    Autoimmun Rev; 2004 Jun; 3(4):261-6. PubMed ID: 15246021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anti-TNF-alpha therapy as a new option in treatment of rheumatoid arthritis?].
    Leeb BF; Sautner J
    Wien Med Wochenschr; 1999; 149(19-20):554-7. PubMed ID: 10637966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytokines in rheumatoid arthritis. I. Proinflammatory cytokines].
    Klimiuk PA; Sierakowski S
    Pol Merkur Lekarski; 2001 Dec; 11(66):510-3. PubMed ID: 11899850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
    Mathsson L; Lampa J; Mullazehi M; Rönnelid J
    Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti-cytokine therapy in inflammatory joint diseases].
    Ehrenfeld M; Langevitz P; Shoenfeld Y
    Harefuah; 1999 Aug; 137(3-4):120-4. PubMed ID: 10959300
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis.
    Channual J; Wu JJ; Dann FJ
    Dermatol Ther; 2009; 22(1):61-73. PubMed ID: 19222518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokine networks--towards new therapies for rheumatoid arthritis.
    McInnes IB; Liew FY
    Nat Clin Pract Rheumatol; 2005 Nov; 1(1):31-9. PubMed ID: 16932625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor necrosis factor inhibitor therapy for rheumatoid arthritis.
    Naguwa SM
    Ann N Y Acad Sci; 2005 Jun; 1051():709-15. PubMed ID: 16127011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of anakinra treatment in rheumatoid arthritis patients previously treated with tumor necrosis factor alpha blockade: comment on the article by Buch et al.
    Saxne T; Larsson L; Geborek P
    Arthritis Rheum; 2004 Sep; 50(9):3049-50; author reply 3050-1. PubMed ID: 15457477
    [No Abstract]   [Full Text] [Related]  

  • 32. Innovative treatment strategies for patients with rheumatoid arthritis.
    van der Kooij SM; Allaart CF; Dijkmans BA; Breedveld FC
    Curr Opin Rheumatol; 2008 May; 20(3):287-94. PubMed ID: 18388520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of bisphosphonates on interleukin 1, tumor necrosis factor alpha, and beta 2 microglobulin in rheumatoid arthritis.
    Cantatore FP; Introsso AM; Carrozzo M
    J Rheumatol; 1996 Jun; 23(6):1117-8. PubMed ID: 8782156
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
    Feldmann M; Brennan F; Paleolog E; Taylor P; Maini RN
    Eur Cytokine Netw; 1997 Sep; 8(3):297-300. PubMed ID: 9346366
    [No Abstract]   [Full Text] [Related]  

  • 35. Rheumatoid arthritis: anticytokine therapies on the horizon.
    Koopman WJ; Moreland LW
    Ann Intern Med; 1998 Feb; 128(3):231-3. PubMed ID: 9454532
    [No Abstract]   [Full Text] [Related]  

  • 36. An update on the cytokine network in rheumatoid arthritis.
    Miossec P
    Curr Opin Rheumatol; 2004 May; 16(3):218-22. PubMed ID: 15103248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prospect for cytokine based therapeutic strategies in rheumatoid arthritis.
    Campion GV
    Ann Rheum Dis; 1994 Aug; 53(8):485-7. PubMed ID: 7944630
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-cytokine therapy in rheumatoid arthritis.
    Elliott MJ; Maini RN
    Baillieres Clin Rheumatol; 1995 Nov; 9(4):633-52. PubMed ID: 8591646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in targeted therapies V: Proceedings of the 5th International Symposium. St Martin, French West Indies. 11-14 April 2003.
    Ann Rheum Dis; 2003 Nov; 62 Suppl 2():ii1-96. PubMed ID: 14532137
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular targets in immune-mediated diseases: the case of tumour necrosis factor and rheumatoid arthritis.
    Campbell IK; Roberts LJ; Wicks IP
    Immunol Cell Biol; 2003 Oct; 81(5):354-66. PubMed ID: 12969323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.